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CI, 3.43–28.30; P <0.001), major vascular compli‑
cation (OR, 12.40; 95% CI, 7.37–20.83; P <0.001), 
and severe anemia (OR, 3.47; 95% CI, 1.95–6.18; 
P <0.001). All of these predictors were associated 
with an increased risk of transfusion of at least 4 
RBC units.4 Unquestionably, there are other fac‑
tors that predict transfusion, such as lower body 
mass index, renal dysfunction, and antiplate‑
let and anticoagulant regimens. Several mecha‑
nisms have been proposed to explain the associ‑
ation of blood transfusion with worse outcomes. 
These include the impairment of oxygen delivery 
due to an increased oxygen affinity and decrease 
in deformability of stored RBCs, prothrombot‑
ic effects through an increased release of proco‑
agulants, and transfusion ‑related modulation of 
the immune system through alterations in cyto‑
kine levels.8 In addition, whether pretreatment 
of anemia (eg, iron substitution, erythropoietin) 
prior to TAVI improves the outcome remains to 
be determined, because anemia may just act as 
an indicator of frailty in these patients. Still, one 
could anticipate that the mitigation of anemia 
could result in a reduction in transfusion rates.9
In this issue of the Polish Archives of Internal 
Medicine, Czerwińska ‑Jelonkiewicz et al10 focused 
on different aspects of blood transfusion in pa‑
tients who underwent TAVI. The authors investi‑
gated the association between RBC storage time 
and the short‑ and long ‑term outcomes in this 
population of patients. In this retrospective, ob‑
servational study, 101 patients (56.7%) required 
blood transfusion during or after TAVI. Given 
that the mean number of transfused RBC units 
was 2 and the mean hemoglobin concentration 
prior to transfusion was 9.6 g/dl, patients were 
managed with a liberal rather than restrictive ap‑
proach to RBC transfusion. One could only spec‑
ulate whether the treatment of preexisting ane‑
mia prior to TAVI could have resulted in a fewer 
Transcatheter aortic valve implantation (TAVI) 
has become a viable therapeutic modality for in‑
operable or high‑surgical‑risk patients with se‑
vere aortic stenosis, who are not deemed suit‑
able for surgical aortic valve replacement. Bleed‑
ing and vascular access site complications range 
from 26% to 77% and 9.5% to 51.6%, respective‑
ly, and have been well documented to be associat‑
ed with worse outcomes.1 Aortic stenosis by itself 
could lead to hemolysis, which in turn may con‑
tribute to anemia. Bleeding events often require 
packed red blood cell (RBC) transfusion. Howev‑
er, the clinical decision regarding the necessity 
of RBC transfusion is challenging. Studies have 
shown that baseline anemia is the strongest pre‑
dictor of the need for RBC transfusion following 
both TAVI and aortic valve replacement.2,3 Not‑
withstanding, everyday clinical practice indicates 
that RBC transfusions are being administered in 
the absence of overt major bleeding or hemody‑
namic instability. More importantly, we must be 
aware that not every major bleeding results in 
a significant hemoglobin drop and thus may not 
require RBC transfusion.
Increased mortality, stroke, and acute kid‑
ney injury rates have been reported in patients 
who received RBC transfusions following TAVI.4 
The adverse effects of bleeding, anemia, and blood 
transfusion on short‑ and long ‑term outcomes 
are not just specific for TAVI. In addition, blood 
transfusion has been linked to worse prognosis 
following acute coronary syndromes,5 percuta‑
neous coronary intervention,6 and cardiac sur‑
gery.7 Tchetche et al4 identified independent pre‑
dictors of RBC transfusion following TAVI. These 
included female sex (odds ratio [OR], 2.11; 95% CI, 
1.32–3.37; P = 0.002), previous cerebrovascular 
accident (OR, 1.95; 95% CI, 1.13–3.38; P = 0.016), 
peripheral vascular disease (OR, 1.94; 95% CI, 
1.18–3.20; P = 0.01), major stroke (OR, 9.85; 95% 
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the risks of systemic inflammatory response, in‑
fectious risk associated with immunomodulation, 
and of organ failure.18 These mechanisms could 
play a central role in everyday clinical practice, as 
most patients receive only buffy ‑coat ‑depleted 
RBCs, which contain more leukocytes than leu‑
kodepleted RBCs. Finally, the oldest erythrocytes 
in each RBC unit are sensitive to prolonged stor‑
age; thus, they may contribute to adverse effects 
of even fresh RBCs due to microparticle forma‑
tion, release of hemoglobin and other intracellu‑
lar components, and iron overload.19,20 A recent 
meta ‑analysis and systematic review has indicat‑
ed that the current evidence provides moderate 
certainty that use of fresher RBCs does not in‑
fluence mortality, and low certainty that it does 
not influence adverse events but could possibly 
increase infection rates.21 In addition, handling of 
the blood products greatly influences the quality 
of both the shorter‑ and the longer ‑stored RBC 
units. Once issued by the blood bank, the trans‑
fusion of RBC units should be commenced with‑
in 30 minutes of removal from the optimal stor‑
age conditions.
The transfusion community seems to be losing 
interest in fierce “new blood – old blood” debates, 
and instead agrees on the need to welcome the op‑
portunity provided by omics/laboratory studies to 
further improve blood storage quality. To estab‑
lish the effect of the storage time of blood prod‑
ucts on clinical outcome, a well ‑controlled clinical 
trial, particularly with a strictly followed storage, 
rewarming, and transfusion protocol, is needed.
In conclusion, although literature data present 
a worrisome picture of potential storage compli‑
cations, current findings are too inconsistent to 
drive changes in clinical practice. Perhaps the re‑
sults of ongoing RCTs will shed new light and con‑
tribute to recommendations on RBC storage time 
in patients undergoing cardiac procedures and in 
those critically ill.
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